Stratec SESRBZF 64 EV-to-FCF is 31.90 as of Jul. 07, 2026, which is 5% below its 10-year median of 33.52. GuruFocus rates SRBZF with a GF Score™ of 64/100 and a GF Value™ of $129.40. The stock has 5 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Stratec SE ranks worse than 63.55% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Stratec SE's Enterprise Value is $378.2 Mil.
Stratec SE's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $11.9 Mil. Therefore, Stratec SE's EV-to-FCF for today is 31.90.
The historical rank and industry rank for Stratec SE's EV-to-FCF or its related term are showing as below:
SRBZF'
s EV-to-FCF Range Over the Past 10 Years
Min: -772.48 Med: 33.52 Max: 692.18
Current: 32.05
During the past 13 years, the highest EV-to-FCF of Stratec SE was 692.18. The lowest was -772.48. And the median was 33.52.
SRBZF's EV-to-FCF is ranked worse than 63.55% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.16
vs SRBZF: 32.05
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Stratec SE's share price for today is $72.9551.
Stratec SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.327.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Stratec SE EV-to-FCF Related Terms
Stratec SE EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Stratec SE's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Stratec SE's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stratec SE EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Stratec SE's EV-to-FCF falls into.
Stratec SE's current Enterprise Value is $378.2 Mil.
Stratec SE's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stratec SE (SRBZF) has a EV-to-FCF of 31.90 as of Jul. 07, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Stratec SE and its competitors. This is near median its historical median of 33.52. According to the industry distribution chart, Stratec SE ranks #265 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 63.5%.
Is Stratec SE's EV-to-FCF too high?
Stratec SE's current EV-to-FCF of 31.90 is near median its 10-year median of 33.52. The Medical Devices & Instruments industry median EV-to-FCF is 23.16. Stratec SE's value of 31.90 is 37.7% above this industry median. Based on the distribution chart, Stratec SE ranks #265 out of 417 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Stratec SE has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Stratec SE's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Stratec SE ranks #265 out of 417 companies for EV-to-FCF. This places Stratec SE in the lower half of its industry. The industry median EV-to-FCF is 23.16. Stratec SE's value of 31.90 is 37.7% above this benchmark. While the company's 10-year median is 33.52 vs. the industry median of 23.16, Stratec SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.16, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stratec SE's current EV-to-FCF of 31.90 is 37.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Stratec SE and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stratec SE's current EV-to-FCF is 31.90, which is near median its own 10-year median of 33.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stratec SE stock overvalued right now?
Stratec SE (SRBZF) has a current EV-to-FCF of 31.90. The stock's GF Value™ is $129.40, compared to a current price of $72.96 — trading 43.6% below its estimated fair value. The current EV-to-FCF is 31.90, which is near median its 10-year median of 33.52 and 37.7% above the Medical Devices & Instruments industry median of 23.16. Stratec SE's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Stratec SE (SRBZF), the current EV-to-FCF is 31.90 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stratec SE (SRBZF) Overvalued in 2026?
Based on GuruFocus' analysis, Stratec SE stock appears to be undervalued.
The current stock price of $72.96 is trading 43.6% below its estimated GF Value™ of $129.40.
Key valuation signals for SRBZF:
EV-to-FCF: 31.90 (near median its 10-year median of 33.52)
GF Value™: $129.40 vs. price of $72.96 (43.6% below fair value)
Industry Position: 37.7% above the Medical Devices & Instruments median (#265 of 417)
No single metric tells the full story. See the SRBZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stratec SE designs and manufactures automation solutions for regulated laboratory markets. STRATEC acts as an OEM partner to players in the in-vitro diagnostics and life sciences markets. The Group's product range includes both hardware solutions, software solutions, and related consumables, as well as independently marketed consumables. These products are mostly combined into fully integrated system solutions and often receive market approval together with partners' reagents.
64GF Score
Get the complete analysis for SRBZF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRBZF has been successfully added to your 
